America’s largest private equity-held hospital operator Steward Health Care looks to be eyeing up a number of Southeast European countries, while its deal to run half of Malta’s public hospitals attracts scrutiny.
Listed Romanian healthcare group Medlife is looking to neighbouring countries for expansion, says its CEO. We analyse the opportunity in the four that he singled out, each of which is ripe for consolidation.
Healthcare Europa speaks to Giuseppe Recchi, CEO of pan-European advanced diagnostic imaging specialist Affidea, to find out about the company’s foray into outpatient care, the state of AI, and plans for the future.
Private equity investor Mid Europa has entered the Serbian private healthcare market for the first time, with the acquisition of hospital operator MediGroup. We speak to a partner at seller Blue Sea Capital.
Eastern European hospital group Penta Hospitals' enterprising CEO Attila Vegh was the surprising choice to replace the soon-to-be-departing CEO of pan-European hospital group Capio, Thomas Beglund. But with Vegh's fingerprints all over Penta's plans for expansion - and his face still all over its website - where does the Czechia-based group go from here. Healthcare Europa speaks to a lawyer whose firm has advised the group in the past to find out more.
Many health care service groups have a multiplicity of different brands. MediGroup, a Serbian health care group with 2017 revenues of €30m chose to align all its operations under one brand and created a new communication platform around the question “How are you today?” The result was a 3% increase in brand awareness in one year alongside a 10% increase in calls and 18% increase in visits.
CT scans, particularly in emergency settings, can generate high doses of radiation. Affidea has rolled out a programme across its 235 centres in 16 countries which prescribes levels for 72 different CT scans. This is based on its database of 75,000 examinations a month. This has led to Affidea creating 105 unified protocols to standardize operating procedures for CT scans. This program is key to Affidea’s strategy for winning international tenders.
In a wide-ranging interview, we look at Affidea’s strategy and view of the market covering everything from partnerships with AI outfits, elite hospitals and payors through to the growth of private pay and the opportunities to manage entire health systems. How will the imaging services and radiotherapy group with HBI estimated sales of around €370m in 2017 grow and build over the next five years?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
